Empagliflozin in Pulmonary Arterial Hypertension

Clinical trial NCT05493371 · COMPLETED

Trial details

NCT number: NCT05493371
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Arterial Hypertension

Start date: 2023-03-01
Primary completion: 2024-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.